Moreover, the conolidine molecule did not connect with the classical receptors, which means that it would not compete in opposition to opioid peptides to bind to these receptors.Researchers think that blocking this scavenger receptor means that it might not stop Normally manufactured opioids from interacting with other opioid receptors that endorse